Fracture risk, persistence with therapy, and gastrointestinal healthcare utilization in a claims analysis of bisphosphonate therapy for osteoporosis
Publication
, Journal Article
Gold, DT; Martin, B; Freytak, J; Amonkar, M; Cosman, F
Published in: Mayo Clinic Proceedings
2005
Duke Scholars
Published In
Mayo Clinic Proceedings
Publication Date
2005
Related Subject Headings
- 11 Medical and Health Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Gold, D. T., Martin, B., Freytak, J., Amonkar, M., & Cosman, F. (2005). Fracture risk, persistence with therapy, and gastrointestinal healthcare utilization in a claims analysis of bisphosphonate therapy for osteoporosis (Submitted). Mayo Clinic Proceedings.
Gold, D. T., B. Martin, J. Freytak, M. Amonkar, and F. Cosman. “Fracture risk, persistence with therapy, and gastrointestinal healthcare utilization in a claims analysis of bisphosphonate therapy for osteoporosis (Submitted).” Mayo Clinic Proceedings, 2005.
Gold DT, Martin B, Freytak J, Amonkar M, Cosman F. Fracture risk, persistence with therapy, and gastrointestinal healthcare utilization in a claims analysis of bisphosphonate therapy for osteoporosis (Submitted). Mayo Clinic Proceedings. 2005;
Gold, D. T., et al. “Fracture risk, persistence with therapy, and gastrointestinal healthcare utilization in a claims analysis of bisphosphonate therapy for osteoporosis (Submitted).” Mayo Clinic Proceedings, 2005.
Gold DT, Martin B, Freytak J, Amonkar M, Cosman F. Fracture risk, persistence with therapy, and gastrointestinal healthcare utilization in a claims analysis of bisphosphonate therapy for osteoporosis (Submitted). Mayo Clinic Proceedings. 2005;
Published In
Mayo Clinic Proceedings
Publication Date
2005
Related Subject Headings
- 11 Medical and Health Sciences